Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 13 of 35

TERMINATED Phase 2

Efficacy of Diuretics in Kidney Disease

NCT04542304

COMPLETED NA

Effects of Different Tidal Volume Ventilation Strategies on Fontan Flow and Hemodynamics

NCT04633343

COMPLETED NA

Recovery of Ventilation After Anesthesia for Laparoscopic Nephrectomy

NCT04723433

TERMINATED NA

Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

NCT04376242

TERMINATED Phase 1

Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging

NCT04514692

COMPLETED Phase 3

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

NCT04253626

COMPLETED NA

Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast Cancer

NCT05114525

TERMINATED Phase 2

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

NCT04511026

COMPLETED

COMT Activity and Hypnotizability

NCT04624880

COMPLETED NA

Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

NCT05153629

COMPLETED Phase 2

Magnesium for Peroral Endoscopic Myotomy

NCT04638881

COMPLETED Phase 2

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

NCT04524663

COMPLETED NA

Insul-In This Together Program for Adolescents With Type 1 Diabetes and Their Parents

NCT04589689

COMPLETED NA

Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

NCT04508725

COMPLETED NA

Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID

NCT04450771

COMPLETED Phase 2

Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation

NCT04258046

COMPLETED NA

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

NCT04298242

COMPLETED NA

Implementing FBT for Adolescent AN for Providers in Private Practice

NCT04428580

COMPLETED NA

Rapid Turnaround, Home-based Saliva Testing for COVID-19

NCT04568122

COMPLETED Phase 1

PET/MRI in the Diagnosis of Pediatric Chronic Pain

NCT04435821

TERMINATED

Breath Metabolomics in the Laboring Parturient

NCT04564196

COMPLETED NA

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

NCT04547023

COMPLETED NA

Social Anxiety Telehealth Therapy Study

NCT04450303

TERMINATED

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy

NCT03802214

COMPLETED NA

Transcranial Magnetic Stimulation for BECTS

NCT04325282

COMPLETED NA

Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer

NCT04389918

COMPLETED NA

THRIVE Use in Pediatric Populations- Multi Site

NCT04322994

TERMINATED Phase 2

Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging

NCT04130438

COMPLETED

Nerve Growth Factor for the Treatment of Cornea Disease

NCT04552730

TERMINATED Phase 2

Low-dose Naltrexone for Bladder Pain Syndrome

NCT04450316

COMPLETED NA

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

NCT04498208

COMPLETED NA

Lay Health Worker Expanded Intervention in Community Oncology Practices

NCT04463992

TERMINATED NA

Bariatric Atrial Restoration of Sinus Rhythm

NCT04050969

COMPLETED NA

Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm

NCT04551014

COMPLETED NA

Evaluation of Cold Forcep and Cold Snare Polypectomy for Polyps Less Than or Equal to 3mm in Size During Colonoscopy

NCT04551001

COMPLETED Phase 2

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

NCT04552769

COMPLETED NA

Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch

NCT04379921

TERMINATED Phase 4

Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions

NCT04278833

COMPLETED NA

Documentary to Encourage Plant-based Eating

NCT04507087

COMPLETED NA

Augmented Reality Medical Simulation

NCT04376255

COMPLETED Phase 1

PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)

NCT04347954

COMPLETED Phase 1

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

NCT04504318

COMPLETED Early Phase 1

The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology

NCT04463394

COMPLETED Phase 3

Convalescent Plasma in Outpatients With COVID-19

NCT04355767

COMPLETED NA

Decentralized Trial in Atrial Fibrillation Patients

NCT04471623

COMPLETED

Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure

NCT04549142

COMPLETED

Pulse Oximeter for Sleep Evaluation

NCT04612114

COMPLETED Phase 2

Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19

NCT04346628

COMPLETED NA

DBT-Based Parenting Intervention for Parents of Youth at Risk for Suicide

NCT04132284

COMPLETED NA

Hoarding Disorder Treatment With Virtual Reality

NCT03828461

← Previous Page 13 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.